RecruitingNCT05913960
Accelerated iTBS compared with high-frequency or sham TMS for depression
About this title
Read the official source — NCT05913960Device studyAges 12–45China
Understand this study
Who could participate?
Listed age limits: 12 years to 45 years.
- Listed locations
- HangzhouSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 9, 2023
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 90
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Sponsor type
- University
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Not clearly listed
- Locations
- China
- Age range
- From 12 Years to 45 Years
- Official registry ID
- NCT05913960
- Official title
Show the full official title
the Mechanism of Accelerated Intermittent Theta Burst Stimulation for Rapid Treatment of Major Depressive Disorder Based on the Prefrontal Excitation-inhibition Balance Regulated by CAMKII Pathway
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Hangzhou
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is First Affiliated Hospital of Zhejiang University, a university.
Who can participate?
Listed age limits: 12 years to 45 years.
Is this study still recruiting?
The registry lists this study as recruiting.
